NeuroPace

company

About

NeuroPace develops and markets implantable devices for the treatment of neurological disorders.

  • 101 - 250

Details

Last Funding Type
Grant
Last Funding Money Raised
$9.30M
Industries
Health Care,Manufacturing,Medical Device,Neuroscience
Founded date
Jan 1, 1997
Number Of Employee
101 - 250
Operating Status
Active

NeuroPace designs develops, manufactures, and markets implantable devices for the treatment of neurological disorders. It offers a responsive Neurostimulator system (RNS) for the treatment of medically refractory partial epilepsy. The company's RNS system consists of implantable components, including RNS neurostimulator that delivers a short train of electrical pulses to the brain, and depth leads and cortical strip leads; and external products, such as the programmer, a laptop computer with proprietary software that has a wand and telemetry interface enabling communication with an implanted RNS neurostimulator.

NeuroPace was incorporated in 1997 and is based in Mountain View, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$58.30M
NeuroPace has raised a total of $58.30M in funding over 2 rounds. Their latest funding was raised on Jun 30, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 30, 2021 Grant $9.30M 1 National Institutes of Health Detail
Aug 31, 2011 Series Unknown $49M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
NeuroPace is funded by 2 investors. National Institutes of Health and Cutlass Capital are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cutlass Capital Series Unknown